The Global Glucagon Like Peptide 1 Analogs Market Growth Accelerated By Rising Prevalence Of Diabetes

 

Analogs Market 

Glucagon like peptide 1 analogs are effective therapeutics for the management and treatment of type 2 diabetes. They mimic the effects of endogenous glucagon-like peptide-1 (GLP-1), a peptide produced in the gut and one of the key incretin hormones, which has multiple effects like stimulating insulin secretion, reducing glucagon output, increasing satiety and slowing gastric emptying. Glucagon like peptide 1 analogs offer advantages like negligible risk of hypoglycemia, helping patients achieve glycemic control along with modest weight reduction and low risk of side effects like nausea. The global Glucagon Like Peptide 1 Analogs Market is estimated to be valued at US$ 11.87 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising prevalence of diabetes has been a key growth driver for the GLP-1 analogs market. According to the International Diabetes Federation, around 537 million adults were living with diabetes in 2021 globally and the number is projected to rise to 643 million by 2030 and 783 million by 2045. GLP-1 analogs are an effective alternative for patients failing on conventional anti-diabetic regimens and this growing diabetes patient pool requiring advanced therapeutics has boosted the demand for GLP-1 receptor agonists. The promising clinical profile of GLP-1 analogs with documented cardiovascular benefits has further increased their adoption over other anti-diabetic agents.
Segment Analysis
The global glucagon like peptide 1 analogs market is dominated by twice-daily GLP-1 receptor agonists sub segment due to its greater efficacy and continuity in controlling blood glucose levels over a longer period. These sub segment drugs help control post-prandial and fasting plasma glucose in patients with type 2 diabetes.

Key Takeaways
The global glucagon like peptide 1 analogs market growth is expected to witness high growth over the forecast period. Regionally, North America dominated the market in 2023 due to high prevalence of diabetes and increasing awareness and adoption of GLP-1 receptor agonist drugs in the region. Europe was the second largest regional market due to rising geriatric population and increasing healthcare expenditure in European countries.

Regional analysis
North America is expected to continue dominating the glucagon like peptide 1 analogs market during the forecast period, growing at a CAGR of 7.5%. This is attributed to rising incidence of diabetes, growing adoption of advanced treatment options, and presence of major players in the region. Europe is anticipated to be the second largest regional market growing at a CAGR of 8.2% between 2023-2030.

Key players
Key players operating in the glucagon like peptide 1 analogs market are Koru Pharmaceuticals Co. LTD, Galderma Laboratories L.P., and DERMEDICS International. Koru Pharmaceuticals Co. LTD offers GLP-1 receptor agonist drugs for type 2 diabetes treatment. Galderma Laboratories L.P. manufactures injectable medications for glucose regulation. DERMEDICS International provides dermatological and aesthetic solutions.

Get more insights on this topic https://www.newswirestats.com/analogs-market-industry-insights-trendsanalogs-market-2023-2030/

Comments

Post a Comment

Popular posts from this blog

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

Image
  Coffee Market  Coffee is a popular beverage consumed worldwide for its stimulant properties and unique flavor. Coffee beans contain caffeine that stimulates the central nervous system and increases energy levels. Major products in the coffee market include whole coffee beans, ground coffee, coffee pods, instant coffee, and canned or bottled coffee. Coffee promotes mental clarity and alertness and offers antioxidant and anti-inflammatory benefits. The global coffee market is estimated to be valued at US$ 132.99 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for coffee from the millennial and Gen Z population is one of the key trends driving the growth of the global coffee market. Millennials and Gen Z are the primary consumers and account for over 50% of total coffee consumption globally. These younger demographics v...
Read more

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

Image
Ammonium Nitrate Market   Ammonium nitrate is an extensively used fertilizer, which is inexpensive and highly effective. It contains nitrogen, a major nutrient needed for plant growth and development. It provides plants with a continuous and balanced supply of nitrogen which helps in increasing crop yields. The ammonium nitrate market is driven by the growing agriculture sector across the globe. The increasing global population has accelerated the demand for food, resulting in high usage of for boosting agricultural production. The global ammonium nitrate market is estimated to be valued at US$ 21.18 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand from agriculture is one of the major trends fueling the growth of the ammonium nitrate market. Agriculture accounts for over 80% of the ammonium nitrate consumption globally....
Read more

The Global Biopharmaceuticals Market Growth Accelerated By Innovation In Product Development

Image
  Biopharmaceuticals Market  Biopharmaceuticals including monoclonal antibodies, vaccines, stem cell and gene therapy have significantly improved the treatment of various life-threatening diseases like cancer, infectious diseases and rare genetic disorders. These biologics are developed in living systems and are highly complex entities. The global Biopharmaceuticals Market is estimated to be valued at US$ 397.24 Bn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth of the biopharmaceuticals market is the continuous innovation in the development of novel products. Biopharmaceutical companies are extensively investing in research and development to come up with more effective and targeted treatment solutions. They are leveraging advanced technologies like gene therapy and cellular therapies to develop next-g...
Read more